Pegsunercept seems to be safe and efficacious at an 800 µg/kg dose; however, further dose-finding studies are warranted, as higher dosages or more frequent dosing might improve response rates ...

HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...

WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for ...

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than ...

Get Instant Summarized Text (Gist) Ivarmacitinib, a selective JAK1 inhibitor, is effective and tolerable for adults with severe alopecia areata at doses of 4 mg and 8 mg. In a phase 3 trial, 34.9% ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 ...